Download slide highlights from our live symposium.
Learn from expert faculty as they respond to the most pressing questions on evolving paradigms in ART, including two-drug regimens and long-acting injectable therapy.
Download slide highlights of expert faculty responses to the most pressing clinician questions on novel ART.
Watch this on-demand Webcast of a CCO symposium at IAS 2019 to gain expert perspectives on evolving paradigms in ART, including two-drug regimens and long-acting injectable therapy. Learn from an international faculty panel as they engage in detailed discussions about novel ART approaches.
Current HIV guidelines limit their recommendations for dual ART, but I expect positive data will soon change this.
The question of which patients are candidates for long-acting ART might be a question of which patients want it.
Less frequent dosing may be a welcome theme among HIV drugs under investigation.
Why I believe as many as 70% of my patients will be interested in long-acting injectable ART.